Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Filbert who wrote (1117)	8/6/1998 2:00:00 PM
From: crysball	Read Replies (1) of 1491

The Pharmos Business Model says license. Dr. Aviv conceived and executed a 'unique' business model, which will deliver more 'bang for the buck'. Rather than tie up very scarce cash resources in bricks & mortar of manufacturing or manpower (sales & marketing), they license these aspects to companies which alrady have organizations in place.......getting to market more quickly for far less invested capital. Others pharmaceutical companies will emulate the Pharmos model awhen the market finally awakens to what PARS has/will accomplish. Others posters have observed PARS has invested $72million and 7 or 8 years to reach this point, but there have been many detours and false starts along the way, which will not be repeated going forward (assumes Dr. Aviv has learned from this arduous experience). PARS is doing so many things right..........it is only a matter of time before others [lke analysts and investors] begin to recognize just how ingenious this business model is.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next